Central serous chorioretinopathy
Conditions
Interventions
Photodynamic therapy was carried out in 1/2 dose, usually used for age-related macular degeneration, and the amount of visudain was measured before, during, 2 weeks after operation, 1 month, 3 months,
Sponsors
Toho University Omori Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: A case of subretinal fluid present in the foveal region over 3 months Examples of difficulty with photocoagulation treatment due to escape from the fovea central fossa and extensive leakage Cases from 20 to 70 years old
Exclusion criteria
Exclusion criteria: (1) Examples in which photodynamic therapy was previously performed or local retinal photocoagulation for treating central serous chorioretinopathy (2) Complicated cases of choroidal neovascularization or other macular diseases (3) Combination of choroidal diseases that may affect the thickness of the choroid (4) Examples of anti-VEGF drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation items of central serous chorioretinopathy were evaluated by visual acuity, foveal retinal thickness, choroidal thickness, ocular blood flow, fluorescence ocular fundus angiography examination, before, 2 weeks, 1 month, 3 months after the evaluation To | — |
Countries
Japan
Contacts
Public ContactShun Kumashiro
Toho University Omori Medical Center Ophthalmology
Outcome results
None listed